Alphamed Formulations Private Limited, a active private limited company, was established on 20 November 2006 in Shamirpet, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2006PTC051732. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹81.93 Cr.
It upholds a compliant status. Employing 562 professional, Its leadership includes Ramesh Cheruvu (Whole-Time Director), Chris Mynhard Botha (Director), Lorraine Angela Hill (Director). Past directors included Vikram Bery, Bala Murali Krishna Thippabhotla, Shekhar Reddy Gangula. It holds ₹9.50 M open charges and ₹2.10 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No. 225, Sampanbole Village Shamirpet Mandal,, Shamirpet, Telangana, 500078.
U24239TG2006PTC051732
051732
20 November 2006
₹95.00 Cr
₹81.93 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Alphamed Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Cheruvu | Whole-Time Director | 12 Jun 2018 | Current |
| Chris Mynhard Botha | Director | 13 Oct 2023 | Current |
| Lorraine Angela Hill | Director | 12 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Jun 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 30 Nov 2018 | Past |
| Pramod Abcsdd | Managing Director | 23 Apr 2013 | Past |
| Pramod Abcsdd | Director | 23 Apr 2013 | Past |
| Pramod Abcsdd | Director | 30 Nov 2018 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alphamed Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.87% increase. The company also saw a substantial fall in profitability, with a 88.95% decrease in profit. The company's net worth Soared by an impressive increase of 29.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Alphamed Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,500,000.00
₹20,950,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2023 | State Bank Of India | ₹9.50 M | Open |
| 27 Aug 2008 | State Bank Of India | ₹0.95 M | Satisfied |
| 24 Aug 2007 | State Bank Of India | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Alphamed Formulations has a workforce of 562 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alphamed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alphamed Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Venkata Narayana Pullela was appointed as a Company Secretary was appointed as a Company Secretary on 09 Apr 2025 & has been associated with this company since 7 months 21 days . was completed.
Progress on A charge with State Bank Of India of Rs. 0.95 Cr registered on 29 Sep 2023 with Charge ID 100795318 was modified on 19 Dec 2024. was documented.
Progress on Alphamed Formulations Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Alphamed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Chris Mynhard Botha was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 2 years 1 month . was recorded as a recent event.
Progress on A charge registered on 24 Aug 2007 via Charge ID 10065860 with State Bank Of India was fully satisfied on 05 Oct 2023. was documented.
Laurus Labs buys Phekolong Pharmaceuticals for ZAR 75,000. Deal to be done by November. Laurus gets access to South African ARV market, while Aspen will still make ARVs for public sector. Laurus also makes APIs for cancer and other diseases..
Aspen plans to license intellectual property rights owned by Laurus..
The CIN of Alphamed Formulations Private Limited is U24239TG2006PTC051732.
Alphamed Formulations Private Limited is headquartered at Survey No. 225, Sampanbole Village Shamirpet Mandal,, Shamirpet, Telangana, 500078.
Alphamed Formulations Private Limited was incorporated on 20 November 2006.
The current directors of Alphamed Formulations Private Limited are
The primary industry of Alphamed Formulations Private Limited is Manufacturing.
Alphamed Formulations Private Limited is unlisted.
The authorized capital of Alphamed Formulations Private Limited is ₹95.00 Cr, and the paid-up capital is ₹81.93 Cr.
The compliance status of Alphamed Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX